What Researchers Did
Researchers conducted a MEDLINE search to review the impact of anemia and tumor hypoxemia on cancer patients' quality of life and survival, and to assess problems associated with correction methods.
What They Found
Approximately 40-64% of cancer patients undergoing therapy are anemic, a rate that increases with chemotherapy, radiotherapy, and hormonal therapy. Anemia is linked to reduced quality of life and decreased survival, with tumor hypoxemia potentially contributing to tumor growth and treatment resistance.
What This Means for Canadian Patients
Canadian patients undergoing cancer treatment should discuss symptoms of anemia, such as fatigue or shortness of breath, with their oncology team. Addressing anemia can potentially improve their quality of life and response to cancer treatments.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a review, this study's findings are dependent on the scope and quality of the existing literature included in the MEDLINE search.